14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Jun 12, 2023 $40.73 $41.67 $40.48 $41.63 952 594
Jun 09, 2023 $41.73 $41.82 $40.49 $40.65 1 433 512
Jun 08, 2023 $40.50 $41.89 $40.17 $41.65 6 496 215
Jun 07, 2023 $40.49 $41.59 $40.24 $40.55 5 540 583
Jun 06, 2023 $42.43 $43.39 $42.31 $43.33 830 816
Jun 05, 2023 $41.41 $42.39 $41.28 $42.26 834 563
Jun 02, 2023 $43.26 $43.40 $41.17 $41.75 959 017
Jun 01, 2023 $41.32 $43.06 $40.86 $42.94 1 414 449
May 31, 2023 $40.59 $41.25 $40.15 $40.90 1 086 260
May 30, 2023 $40.64 $41.66 $40.06 $40.55 1 332 269
May 26, 2023 $40.73 $40.85 $38.84 $40.74 1 048 375
May 25, 2023 $41.00 $41.62 $38.98 $39.17 1 636 519
May 24, 2023 $42.20 $42.52 $41.21 $41.28 1 464 060
May 23, 2023 $40.93 $43.55 $40.93 $42.28 2 084 211
May 22, 2023 $39.17 $40.83 $39.10 $40.71 1 524 739
May 19, 2023 $36.83 $39.35 $36.37 $39.19 1 827 694
May 18, 2023 $36.26 $36.73 $35.93 $36.63 1 206 077
May 17, 2023 $36.06 $36.31 $35.44 $36.30 1 016 418
May 16, 2023 $35.84 $36.06 $34.99 $35.99 958 804
May 15, 2023 $35.50 $36.41 $35.50 $36.24 797 282
May 12, 2023 $35.74 $35.76 $35.36 $35.51 572 836
May 11, 2023 $35.89 $35.89 $35.05 $35.59 643 146
May 10, 2023 $36.06 $36.80 $35.31 $35.83 707 999
May 09, 2023 $34.92 $36.20 $34.79 $35.70 831 183
May 08, 2023 $36.09 $36.09 $35.12 $35.18 719 472
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT